Stock Screener App

Frei -

Installieren

13.68

0.74% 0.10

after-market

Handel nachbörslich: 13.77 0.09 +0.66%

Amylyx Pharmaceuticals Inc (AMLX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-0.665
Cost Of Revenue	-	-	-	-	-
Selling, General, and Administrative	4.82% 15.39	16.17	15.64	15.68	-
Costs And Expenses	1.60% 36.60	36.03	42.86	37.80	39.99
Operating Income/Loss	1.60% -36.60	-36.03	-42.86	-37.80	-40.65
Nonoperating Income/Loss	122.55% 3.652	1.641	1.414	1.896	2.473
Income/Loss From Continuing Operations Before Tax	4.17% -32.95	-34.39	-41.44	-35.91	-38.18
Income Tax Expense/Benefit	0.046	-	-	-	-0.635
Income/Loss From Continuing Operations After Tax	4.03% -33.00	-34.39	-41.44	-35.91	-37.55
Net Income/Loss	4.03% -33.00	-34.39	-41.44	-35.91	-37.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.48% 5.1481	93.33	89.14	85.70	0.1515
Diluted Average Shares	94.48% 5.1481	93.33	89.14	85.70	0.1515
Basic Earnings Per Share	24.32% -0.28	-0.37	-0.46	-0.42	-0.54
Diluted Earnings Per Share	24.32% -0.28	-0.37	-0.46	-0.42	-0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.82

5.02%

RDY

$13.75

1.10%

RGC

$24.31

5.78%

NBIX

$155.73

0.62%

VTRS

$16.26

2.34%

UTHR

$578.43

1.76%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters